Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2007
02/14/2007CN1911232A Theophylline chitin micro-balls slow-release prepn., and its prepn. method
02/14/2007CN1911231A Medicine for treating burns
02/14/2007CN1911230A Cancer treatment
02/14/2007CN1911229A Compounding injection contg. Ticarcillin Disodium and Sulbactam
02/14/2007CN1911228A Nasal cavity gel contg. levomisole, and its new use
02/14/2007CN1911227A Novel prepn. of levomisole, and its new use
02/14/2007CN1911226A Novel prepn. of thiabendazole, and its new use
02/14/2007CN1911225A Compound chlorazol fensuanna (Tongbixiao), and its prepn. method
02/14/2007CN1911224A Nasal cavity gel contg. membendazole, and its new use
02/14/2007CN1911223A Prepn. of mebendazole for treating adenoid hypertrophy
02/14/2007CN1911222A Clonidine, weekly-effect, skin-permeable and control-released plaster
02/14/2007CN1911221A Use of a hypoglycemic agent for treating impaired glucose metabolism
02/14/2007CN1911220A Injection contg. seven vitamins and taurine
02/14/2007CN1911219A Medicine composition, and its application for treating diseases of cardiovascular and cerebrovascular
02/14/2007CN1911218A Combinations comprising epothilones and pharmaceutical uses thereof
02/14/2007CN1911217A Oral disintegration tablets of Bingpazhe germanium for treating chronic hepatitis and its making method
02/14/2007CN1911216A Medicated chitin fiber for treating and preventing proliferation of mammary gland, prepn. method and application thereof
02/14/2007CN1911215A Application of gossypol and its derivatives for preparing medicine for treating leukemia
02/14/2007CN1911213A Soft capsule of atovastatine salts and prepn. method therefor
02/14/2007CN1911212A Method for prodn. of dripping pills of andrographolide
02/14/2007CN1911211A Solid oral prepn. of leishajilan
02/14/2007CN1911210A Dispersing tablets of nizatidine, and its prepn. method
02/14/2007CN1911209A Quick-disintegration tablets of calcium atovastatine, and its prepn. method
02/14/2007CN1911208A Injection of Jiabei mesylate and its prpen. method
02/14/2007CN1911207A Oral liquor contg. citalopram hydrobromide and its prepn. method
02/14/2007CN1911017A Synergistic microbicidal combination
02/14/2007CN1911016A Synergistic microbicidal combination
02/14/2007CN1300176C New saponin and its derivative, its preparation method and its use in medicine
02/14/2007CN1300175C Medicinal polysaccharide component of spinulate hedgehog fungus, its prepn and medicinal composition comprising same as active component
02/14/2007CN1300173C Human antibodies that bind huma TNF 'alpha'
02/14/2007CN1300165C 3-b-d-ribofuranosylthiazolo [4,5-d] pyridimine nucleosides and uses thereof
02/14/2007CN1300164C Method for extracting vitexin, use and preparation
02/14/2007CN1300163C 3-hydroxy-chromogen ketoside and its preparation and use
02/14/2007CN1300160C Fatty acid ester compounds of ginsenoside secondary glycoside compound K and method for preparing same
02/14/2007CN1300159C Ibuprofen sugar derivative and its preparing process and use
02/14/2007CN1300158C Non-natural active oligosaccharide compounds, preparing process and application
02/14/2007CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
02/14/2007CN1300130C Rosa banksiae general lactone extract and its preparing process and application
02/14/2007CN1300129C Compound of 3,15-dicarbonyl erythro mildew acid kind and its ester and salt
02/14/2007CN1300126C Application of 3-hydroxyphenyl phthale compound in preparing culicifuge
02/14/2007CN1300114C Phenylpyridine carbonyl piperazine derivative
02/14/2007CN1300113C Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors
02/14/2007CN1300111C Process for the preparation of high purity perindopril and intermediates useful in the synthesis
02/14/2007CN1300110C Hydroxamate derives useful as deacetylase inhibitors
02/14/2007CN1300099C Vermin-repellant compositions and compounds
02/14/2007CN1300083C Biphenyl undecanone compounds with anticancer activity
02/14/2007CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques
02/14/2007CN1299771C Colorstrum-based composition
02/14/2007CN1299753C Chinese medicinal composition, its preparation method and quality control method
02/14/2007CN1299750C Health article for nourishing Yin, enriching blood, and nourishing skin and hair and its preparing method
02/14/2007CN1299717C Pharmaceutical composition for treating cerebral apoplexy and its preparation method
02/14/2007CN1299710C Xiguashuang eye medicine and preparation process thereof
02/14/2007CN1299704C Prescription of body surface shielding film and its preparing method
02/14/2007CN1299703C Process for preparing broad spectrum anti-virus medicine and its use
02/14/2007CN1299696C Povidone iodine effervescence tablet for treating milk cow colpitis, its preparation process and application
02/14/2007CN1299695C Liquid embolism agent for intracranial aneurysm and its preparing process
02/14/2007CN1299694C Flavone composition for sobering and liver protection and its use
02/14/2007CN1299693C Method for preparing aqueous solution of complex of baicalin zinc
02/14/2007CN1299692C Novel usage of jasminoidin
02/14/2007CN1299691C Telithromycin suspension with a masked taste
02/14/2007CN1299690C Compositions for improving cardiovascular function
02/14/2007CN1299689C Application of alendronate in preparation of drug for inhibitting bone resorption
02/14/2007CN1299688C Amino acid liquor and its preparation method
02/14/2007CN1299687C Ointment for treating vein impairment
02/14/2007CN1299686C Combination of semisolid framework preparation of progesterone
02/14/2007CN1299685C Fluorouracil medicine carrier microsphere and production thereof
02/14/2007CN1299684C Antibacterial for aquatic animal and preparing method
02/14/2007CN1299683C Celecoxib compositions
02/14/2007CN1299682C Use of pyrazoline derivatives in preparation of medicament for prevention and/or treatment of proliferative cell diseases
02/14/2007CN1299681C Health caring formulation for treating insomnia
02/14/2007CN1299680C Black-white formulation for treating insomnia
02/14/2007CN1299679C Preventive or remedy for bedsore
02/14/2007CN1299678C Sulpride dispersion tablets prepn. method
02/14/2007CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
02/14/2007CN1299676C Anti-anoxia medicinal composition
02/14/2007CN1299675C Composition of cupresulflavone and its preparation
02/14/2007CN1299674C Slow released combination of anticancer drugs embedded in vivo
02/14/2007CN1299673C Ambroxol hydrochloride drop pills and its preparation method
02/14/2007CN1299672C Extracts from sophora,production method and purposes thereof
02/14/2007CN1299669C Mini pills for treating cold and its preparation method
02/13/2007US7176327 Water soluble, biologically inert Pt(IV) compounds which can be converted to cytotoxic Pt(II) species by photoactivation; reduced side effect anticancer drugs
02/13/2007US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine
02/13/2007US7176320 Benzimidazole derivative
02/13/2007US7176316 Amino-piperidine derivatives
02/13/2007US7176314 Inflammation modulators
02/13/2007US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance
02/13/2007US7176312 Kinase inhibitor scaffolds and methods for their preparation
02/13/2007US7176311 Process for preparing pharmaceutically active compounds
02/13/2007US7176308 Purification; chemical synthesis; photosensitive coloring material; use for coating an optical disc for copy-protection
02/13/2007US7176302 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome and is
02/13/2007US7176276 Antimicrobial peptide and use thereof
02/13/2007US7176256 Reacting by crosslinking a first synthetic polymer containing multiple nucleophilic groups such as amino groups, with a second synthetic polymer containing multiple electrophilic groups such as succinimidyl groups to covalently bind them; use to prevent surgical adhesions, coat implants
02/13/2007US7176244 Orally administering to non-ruminant animal for controlling bacterial enteropathogenic Salmonella species, enteric Escherichia coli pathogens, Campylobacter species, or Listeria monocytogenes; may also be applied externally onto the animal
02/13/2007US7176243 CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
02/13/2007US7176240 Such as 5-fluoro-2-propylpentanoic acid for improving GABA (gamma-aminobutyric acid) receptor responses; treatment of neurodegenerative diseases
02/13/2007US7176239 Methods and compositions for treatment of Ataxia-telangeictasia
02/13/2007US7176238 For treating or preventing sexual dysfunctions in males and females, for enhancing sexual responses in males and females, and for treating or preventing cerebrovascular disorders, cardiovascular disorders, benign prostatic hyperplasia, glaucoma, peptic ulcers or for inducing abortions
02/13/2007US7176237 Tricyclic-bis-enone derivatives and methods of use thereof